Quibual, Rohaan M.

HRN: 26-54-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/29/2025
02/05/2025
IV
450mg
Q 6 Hours
PCAP-C
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines